Cyclerion Therapeutics Inc. (CYCN) NASDAQ
$2.84 - (-)
Market Cap: $7.70M
As of 05/07/24 04:30 PM EDT. Market closed.
Cyclerion Therapeutics Inc. (CYCN)
NASDAQ
$2.84
- (-)
Market Cap: $7.70M
As of 05/07/24 04:30 PM EDT. Market closed.
Add to Portfolio
cyclerion therapeutics, inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments for serious and orphan diseases. its product candidates include olinciguat, an orally administered vascular soluble guanylate cyclase (sgc) stimulator that is in phase ii studies for the treatment of sickle cell disease (scd); praliciguat, ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$100,000
CEO Compensation (Total)
$5.16M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
35
CEO Compensation (Base)
$100,000
CEO Compensation (Total)
$5.16M
URL
Address
.
PRICE CHART FOR CYCLERION THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$2.84
Days Range
$2.84 - $2.96
52 week range
$1.75 - $6.75
Volume
1,127
Avg. Volume (30 days)
3,385
Market Cap
$7.70M
Dividend Yield
-
P/E
(0.71)
Shares Outstanding
2,710,096
Open
-
Previous Close
$2.84
Days Range
$2.84 - $2.96
52 week range
$1.75 - $6.75
Volume
1,127
Avg. Volume (30 days)
3,385
Market Cap
$7.70M
Dividend Yield
-
P/E
(0.71)
Shares Outstanding
2,710,096
FINANCIAL STATEMENTS FOR CYCLERION THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR CYCLERION THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
MCGUIRE TERRANCE | Director | Aug 09, 2023 | Sale | $3.39 | 8 | 27 | 0 | Aug 11, 2023, 04:25 PM |
Hecht Peter M | Chief Executive Officer | May 19, 2023 | Option Exercise | $8.68 | 225,000 | 1,953,000 | 327,385 | May 22, 2023, 08:43 PM |
MCGUIRE TERRANCE | Director | Jun 03, 2021 | Buy | $3.12 | 3,322 | 10,365 | 24,957 | Jun 07, 2021, 05:36 PM |
MCGUIRE TERRANCE | Director | Jun 03, 2021 | Buy | $3.12 | 92,831 | 289,633 | 697,313 | Jun 07, 2021, 05:36 PM |
Hecht Peter M | Chief Executive Officer | Jun 03, 2021 | Buy | $3.28 | 823,170 | 2,699,998 | 2,047,698 | Jun 07, 2021, 05:25 PM |
Hecht Peter M | Chief Executive Officer | May 06, 2021 | Buy | $2.43 | 302,000 | 733,860 | 1,224,528 | May 10, 2021, 08:45 AM |
Hecht Peter M | Chief Executive Officer | May 05, 2021 | Buy | $2.53 | 398,001 | 1,006,943 | 922,528 | May 06, 2021, 09:27 PM |
Hecht Peter M | Chief Executive Officer | May 04, 2021 | Buy | $2.29 | 300,000 | 687,000 | 524,527 | May 06, 2021, 09:27 PM |
Gjino Anjeza | Chief Financial Officer | Feb 25, 2021 | Sale | $4.00 | 1,824 | 7,296 | 31,599 | Mar 01, 2021, 04:23 PM |
Wright Christopher I | Chief Medical Officer | Feb 25, 2021 | Sale | $3.99 | 2,637 | 10,522 | 42,728 | Mar 01, 2021, 12:00 AM |
Currie Mark G | President and CSO | Dec 28, 2020 | Sale | $3.01 | 20,107 | 60,522 | 251,648 | Dec 30, 2020, 01:14 PM |
Busch Andreas | Chief Innovation Officer | Nov 09, 2020 | Buy | $2.53 | 125,000 | 316,250 | 254,704 | Nov 12, 2020, 05:05 PM |
Huyett William | Chief Financial Officer | Nov 06, 2020 | Sale | $2.52 | 3,827 | 9,644 | 67,590 | Nov 10, 2020, 07:07 PM |
Huyett William | Chief Financial Officer | Feb 21, 2020 | Sale | $5.12 | 3,559 | 18,222 | 71,417 | Feb 25, 2020, 04:11 PM |
Currie Mark G | President | Dec 30, 2019 | Sale | $2.48 | 25,000 | 62,000 | 271,755 | Dec 31, 2019, 05:55 PM |
Currie Mark G | President | Dec 27, 2019 | Sale | $2.55 | 25,000 | 63,750 | 296,755 | Dec 31, 2019, 05:55 PM |
Busch Andreas | Chief Innovation Officer | Nov 15, 2019 | Buy | $1.82 | 125,000 | 227,500 | 125,000 | Nov 19, 2019, 04:02 PM |
Huyett William | Chief Financial Officer | Nov 08, 2019 | Sale | $2.05 | 3,922 | 8,040 | 74,976 | Nov 12, 2019, 04:26 PM |
Hecht Peter M | Chief Executive Officer | Jul 10, 2019 | Option Exercise | $6.04 | 2,000 | 12,080 | 225,192 | Jul 12, 2019, 04:09 PM |
MCGUIRE TERRANCE | Director | Apr 08, 2019 | Buy | $16.00 | 21,635 | 346,160 | 21,635 | Apr 10, 2019, 04:14 PM |
MCGUIRE TERRANCE | Director | Apr 08, 2019 | Buy | $16.00 | 604,482 | 9,671,712 | 604,482 | Apr 10, 2019, 04:14 PM |
SCHULMAN AMY W | Director | Apr 08, 2019 | Buy | $16.00 | 21,635 | 346,160 | 21,635 | Apr 10, 2019, 04:13 PM |
SCHULMAN AMY W | Director | Apr 08, 2019 | Buy | $16.00 | 604,482 | 9,671,712 | 604,482 | Apr 10, 2019, 04:13 PM |
Currie Mark G | President | Apr 02, 2019 | Buy | $14.81 | 270,107 | 4,000,285 | 321,755 | Apr 03, 2019, 07:42 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
MCGUIRE TERRANCE | Director | 08/09/2023 | 27 |
Hecht Peter M | Chief Executive Officer | 05/19/2023 | 1,953,000 |
MCGUIRE TERRANCE | Director | 06/03/2021 | 10,365 |
MCGUIRE TERRANCE | Director | 06/03/2021 | 289,633 |
Hecht Peter M | Chief Executive Officer | 06/03/2021 | 2,699,998 |
Hecht Peter M | Chief Executive Officer | 05/06/2021 | 733,860 |
Hecht Peter M | Chief Executive Officer | 05/05/2021 | 1,006,943 |
Hecht Peter M | Chief Executive Officer | 05/04/2021 | 687,000 |
Gjino Anjeza | Chief Financial Officer | 02/25/2021 | 7,296 |
Wright Christopher I | Chief Medical Officer | 02/25/2021 | 10,522 |
Currie Mark G | President and CSO | 12/28/2020 | 60,522 |
Busch Andreas | Chief Innovation Officer | 11/09/2020 | 316,250 |
Huyett William | Chief Financial Officer | 11/06/2020 | 9,644 |
Huyett William | Chief Financial Officer | 02/21/2020 | 18,222 |
Currie Mark G | President | 12/30/2019 | 62,000 |
Currie Mark G | President | 12/27/2019 | 63,750 |
Busch Andreas | Chief Innovation Officer | 11/15/2019 | 227,500 |
Huyett William | Chief Financial Officer | 11/08/2019 | 8,040 |
Hecht Peter M | Chief Executive Officer | 07/10/2019 | 12,080 |
MCGUIRE TERRANCE | Director | 04/08/2019 | 346,160 |
MCGUIRE TERRANCE | Director | 04/08/2019 | 9,671,712 |
SCHULMAN AMY W | Director | 04/08/2019 | 346,160 |
SCHULMAN AMY W | Director | 04/08/2019 | 9,671,712 |
Currie Mark G | President | 04/02/2019 | 4,000,285 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CYCLERION THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 31,259 | 0.00001% | 1.66% | Other |
BLACKROCK INC. | 17,169 | 0% | -4.62% | Other |
CHANGE IN SHARES OUTSTANDING FOR CYCLERION THERAPEUTICS INC
STOCK BUYBACKS FOR CYCLERION THERAPEUTICS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-11.88%
1Q
06/30/2023
7.58%
2Q
09/30/2022
12.93%
5Q
BUYBACK ANNOUNCEMENT(S) FOR CYCLERION THERAPEUTICS INC
LOADING...